Managing persistent ovarian follicles in premenopausal women fitted with the levonorgestrel-releasing intrauterine system
Morelli, M.; Di Cello, A.; Zullo, F.
International Journal of Gynaecology and Obstetrics the Official Organ of the International Federation of Gynaecology and Obstetrics 120(2): 187
2013
ISSN/ISBN: 1879-3479 PMID: 23195288 DOI: 10.1016/j.ijgo.2012.10.007Document Number: 574296
Document emailed within 0-6 h
Related Documents
Jiang, W.; Shen, Q.; Chen, M.; Wang, Y.; Zhou, Q.; Zhu, X.; Zhu, X. 2014: Levonorgestrel-releasing intrauterine system use in premenopausal women with symptomatic uterine leiomyoma: a systematic review Steroids 86: 69-78Nahum, G.G.; Kaunitz, A.M.; Rosen, K.; Schmelter, T.; Lynen, R. 2015: Ovarian cysts: presence and persistence with use of a 13.5mg levonorgestrel-releasing intrauterine system Contraception 91(5): 412-417
Tasci, Y.; Caglar, G.S.; Kayikcioglu, F.; Cengiz, H.; Yagci, B.; Gunes, M. 2009: Treatment of menorrhagia with the levonorgestrel releasing intrauterine system: effects on ovarian function and uterus Archives of Gynecology and Obstetrics 280(1): 39-42
Ji, F.; Yang, X.-H.; Ai Xing Zi, A.L.; Ha Ni Ke Zi, T.X.; He, Y.; Ding, Y. 2014: Role of levonorgestrel-releasing intrauterine system in dysmenorrhea due to adenomyosis and the influence on ovarian function Clinical and Experimental Obstetrics and Gynecology 41(6): 677-680
Daud, S.; Ewies, A.A.A. 2008: Levonorgestrel-releasing intrauterine system: why do some women dislike it? Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 24(12): 686-690
Imperato, F.; Perniola, G.; Mossa, B.; Marziani, R.; Perniola, F.; Stragapede, B.; Napolitano, C. 2002: The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years) Minerva Ginecologica 54(3): 271-278
Lan, S.; Ling, L.; Jianhong, Z.; Xijing, J.; Lihui, W. 2013: Analysis of the levonorgestrel-releasing intrauterine system in women with endometriosis Journal of International Medical Research 41(3): 548-558
Soini, T.; Hurskainen, R.; Grénman, S.; Mäenpää, J.; Paavonen, J.; Pukkala, E. 2014: Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland Obstetrics and Gynecology 124(2 Part 1): 292-299
Yoo, H.J.; Lee, M.A.; Ko, Y.B.; Yang, J.B.; Kang, B.H.; Lee, K.H. 2012: The efficacy of the levonorgestrel-releasing intrauterine system in perimenopausal women with menorrhagia or dysmenorrhea Archives of Gynecology and Obstetrics 285(1): 161-166
Monteiro, I.; Bahamondes, L.; Diaz, J.; Perrotti, M.; Petta, C. 2002: Therapeutic use of levonorgestrel-releasing intrauterine system in women with menorrhagia: a pilot study(1) Contraception 65(5): 325-328
Heikinheimo, O.; Lehtovirta, P.äi.; Aho, I.; Ristola, M.; Paavonen, J. 2011: The levonorgestrel-releasing intrauterine system in human immunodeficiency virus-infected women: a 5-year follow-up study American Journal of Obstetrics and Gynecology 204(2): 126.E1-4
Endrikat, J.; Vilos, G.; Muysers, C.; Fortier, M.; Solomayer, E.; Lukkari-Lax, E. 2012: The levonorgestrel-releasing intrauterine system provides a reliable, long-term treatment option for women with idiopathic menorrhagia Archives of Gynecology and Obstetrics 285(1): 117-121
Blumenthal, P.D.; Dawson, L.; Hurskainen, R. 2011: Cost-effectiveness and quality of life associated with heavy menstrual bleeding among women using the levonorgestrel-releasing intrauterine system International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 112(3): 171-178
Suhonen, S.; Haukkamaa, M.; Jakobsson, T.; Rauramo, I. 2004: Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study Contraception 69(5): 407-412
Castro, T.V.B.; Franceschini, S.A.; Poli-Neto, O.; Ferriani, R.A.; Silva de Sá, M.F.; Vieira, C.S. 2014: Effect of intracervical anesthesia on pain associated with the insertion of the levonorgestrel-releasing intrauterine system in women without previous vaginal delivery: a RCT Human Reproduction 29(11): 2439-2445
Jóźwik, M.; Jóźwik, M.; Modzelewska, B.; Niewińska, M.; Jóźwik, Mł. 2015: Levonorgestrel-releasing intrauterine system Mirena® (Bayer) for the prevention and treatment of endometrial adenocarcinoma and the incidence of other malignancies in women Ginekologia Polska 86(4): 305-310
Zhang, P.; Song, K.; Li, L.; Yukuwa, K.; Kong, B. 2013: Efficacy of combined levonorgestrel-releasing intrauterine system with gonadotropin-releasing hormone analog for the treatment of adenomyosis Medical Principles and Practice: International Journal of the Kuwait University Health Science Centre 22(5): 480-483
Yamaguti, E.M.M.; Brito, M.B.; Ferriani, R.A.; Garcia, A.éa.A.; Rosa-e-Silva, J.úl.C.; Vieira, C.S. 2014: Comparison of the hemostatic effects of a levonorgestrel-releasing intrauterine system and leuprolide acetate in women with endometriosis: a randomized clinical trial Thrombosis Research 134(6): 1193-1197
Marshall, M.; Jordan, K.; Brand, J.L.; Welborn, T.L. 2013: In women over 35 years of age who smoke, does mirena (levonorgestrel-releasing intrauterine system) reduce the risk of DVTs compared to oral contraceptives? Journal of the Oklahoma State Medical Association 106(9): 362-363
Dubuisson, J.B.; Mugnier, E. 2002: Acceptability of the levonorgestrel-releasing intrauterine system after discontinuation of previous contraception: Results of a French clinical study in women aged 35 to 45 years Contraception 66(2): 121-128